“…Mitomycin-C has also been associated with endothelial changes in a rabbit, 16 whose endothelium has mitotic activity, unlike the human endothelium, thus making it difficult to extrapolate those results to humans. Torres et al 17 report a detectable concentration of MMC in the anterior chamber after topical application over the cornea, which suggests that the drug comes into contact with the deep stroma and the endothelium, raising the question of possible toxicity in these corneal layers. To our knowledge, only 2 papers 18,19 have reported the differences between endothelial cell counts in a group of patients before and after surface ablation with application of intraoperative MMC, with contradicting and not definitive results.…”